Abstract:At the first sight, the transcription factor Nrf2 as a master regulator of cellular antioxidant systems, and mitochondria as the main source of reactive oxygen species (ROS), should play the opposite roles in determining the pace of aging. However, since the causes of aging cannot be confined to the oxidative stress, the role of Nrf2 role cannot be limited to the regulation of antioxidant systems, and moreover, the role of mitochondria is not confined to the ROS production. In this review, we discussed only one aspect of this problem, namely, the molecular mechanisms of interaction between Nrf2 and mitochondria that influence the rate of aging and the lifespan. Experimental data accumulated so far show that the Nrf2 activity positively affects both the mitochondrial dynamics and mitochondrial quality control. Nrf2 influences the mitochondrial function through various mechanisms, e.g., regulation of nuclear genome-encoded mitochondrial proteins and changes in the balance of ROS or other metabolites that affect the functioning of mitochondria. In turn, multiple regulatory proteins functionally associated with the mitochondria affect the Nrf2 activity and even form mutual regulatory loops with Nrf2. We believe that these loops enable the fine-tuning of the cellular redox balance and, possibly, of the cellular metabolism as a whole. It has been commonly accepted for a long time that all mitochondrial regulatory signals are mediated by the nuclear genome-encoded proteins, whereas the mitochondrial genome encodes only a few respiratory chain proteins and two ribosomal RNAs. Relatively recently, mtDNA-encoded signal peptides have been discovered. In this review, we discuss the data on their interactions with the nuclear regulatory systems, first of all, Nrf2, and their possible involvement in the regulation of the aging rate. The interactions between regulatory cascades that link the programs ensuring the maintenance of cellular homeostasis and cellular responses to the oxidative stress are a significant part of both aging and anti-aging programs. Therefore, understanding these interactions will be of great help in searching for the molecular targets to counteract aging-associated diseases and aging itself.

Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging

NAD+ metabolism and its roles in cellular processes during ageing

Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?

Transcription Factor Nrf2 and Mitochondria - Friends or Foes in the Regulation of Aging Rate

Redox Signaling of NADPH Oxidases Regulates Oxidative Stress Responses, Immunity and Aging

NAD+ Repletion Improves Mitochondrial and Stem Cell Function and Enhances Life Span in Mice

NADH: the redox sensor in aging-related disorders.

Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process

NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging

NAD metabolism: Role in senescence regulation and aging

Vitamin B3, the Nicotinamide Adenine Dinucleotides and Aging

NAD+ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications

Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan

Nicotinamide, Nicotinamide Riboside and Nicotinic Acid—Emerging Roles in Replicative and Chronological Aging in Yeast

Delaying Brain Mitochondrial Decay and Aging with Mitochondrial Antioxidants and Metabolites

NAD+ homeostasis in health and disease

NAD+ Flux is Maintained in Aged Mice

Regulation of and challenges in targeting NAD + metabolism

Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1α Signaling Pathways

Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging

Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells